$REGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in REGENERON PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 41 42 43 44 45 46 47 48 48 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Option Exercise | D | 19.43 | 5,147 | 100,006 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Option Exercise | A | 8.50 | 2,573 | 21,871 | 2,573 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Option Exercise | A | 8.50 | 1,587 | 13,490 | 1,587 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 37.78 | 5,000 | 188,900 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 33.25 | 34,965 | 1,162,586 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 28.01 | 25,000 | 700,250 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 19.43 | 24,854 | 482,913 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 1,715 | 14,578 | 18,284 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 16,569 | 140,837 | 16,569 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 12,500 | 106,250 | 12,500 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 3,158 | 26,843 | 22,306 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 17,482 | 148,597 | 19,148 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 1,666 | 14,161 | 1,666 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 33.25 | 15,035 | 499,914 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | D | 19.43 | 5,146 | 99,987 | 0 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 1,715 | 14,578 | 1,715 | |
| Jan 07 2005 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 8.50 | 4,359 | 37,052 | 4,359 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Fin & Admin, CF ... | Option Exercise | M | 5.63 | 8,800 | 49,500 | 0 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Fin & Admin, CF ... | Buy | M | 5.63 | 8,800 | 49,500 | 38,127 | 29.3 K to 38.1 K (+30.01 %) |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Gift | G | 0.00 | 2,000 | 0 | 17,975 | 20 K to 18 K (-10.01 %) |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Gift | G | 0.00 | 2,000 | 0 | 19,975 | 22 K to 20 K (-9.10 %) |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Gift | G | 0.00 | 2,000 | 0 | 21,975 | 24 K to 22 K (-8.34 %) |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Jan 05 2005 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 9.17 | 15,000 | 137,550 | 15,000 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Option Exercise | A | 9.49 | 18,812 | 178,526 | 18,812 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Option Exercise | A | 9.49 | 11,188 | 106,174 | 11,188 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | ROBERTS WILLIAM | VP, Regulatory Deve ... | Grant | A | 0.00 | 8,399 | 0 | 19,829 | 11.4 K to 19.8 K (+73.48 %) |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 9.49 | 30,000 | 284,700 | 30,000 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Option Exercise | A | 9.49 | 10,000 | 94,900 | 10,000 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Grant | A | 0.00 | 9,590 | 0 | 19,722 | 10.1 K to 19.7 K (+94.65 %) |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | A | 9.49 | 64,463 | 611,754 | 64,463 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | A | 9.49 | 10,537 | 99,996 | 10,537 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Option Exercise | A | 9.49 | 270,352 | 2,565,640 | 270,352 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Option Exercise | A | 9.49 | 42,148 | 399,985 | 42,148 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 24,393 | 0 | 527,322 | 551.7 K to 527.3 K (-4.42 %) |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 20,870 | 0 | 551,715 | 572.6 K to 551.7 K (-3.64 %) |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP, PreclinDevel & ... | Option Exercise | A | 9.49 | 89,463 | 849,004 | 89,463 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP, PreclinDevel & ... | Option Exercise | A | 9.49 | 10,537 | 99,996 | 10,537 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Fin & Admin, CF ... | Option Exercise | A | 9.49 | 64,463 | 611,754 | 64,463 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Fin & Admin, CF ... | Option Exercise | A | 9.49 | 10,537 | 99,996 | 10,537 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | Chief Exec Officer ... | Option Exercise | A | 9.49 | 218,389 | 2,072,512 | 218,389 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | Chief Exec Officer ... | Option Exercise | A | 10.44 | 31,611 | 330,019 | 31,611 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Option Exercise | A | 9.49 | 189,463 | 1,798,004 | 189,463 | |
| Dec 16 2004 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | EVP, CSO, & Pres Re ... | Option Exercise | A | 9.49 | 10,537 | 99,996 | 10,537 | |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.25 | 10,000 | 42,500 | 0 | |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 7.27 | 10,000 | 72,700 | 11,391 | 21.4 K to 11.4 K (-46.75 %) |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.25 | 10,000 | 42,500 | 21,391 | 11.4 K to 21.4 K (+87.79 %) |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.25 | 10,000 | 42,500 | 10,000 | |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 7.33 | 10,000 | 73,270 | 11,391 | 21.4 K to 11.4 K (-46.75 %) |
| Oct 18 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.25 | 10,000 | 42,500 | 21,391 | 11.4 K to 21.4 K (+87.79 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.25 | 5,000 | 21,250 | 20,000 | |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.25 | 5,000 | 21,250 | 25,000 | |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.25 | 20,000 | 85,000 | 30,000 | |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 7.80 | 5,000 | 39,010 | 11,391 | 16.4 K to 11.4 K (-30.50 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.25 | 5,000 | 21,250 | 16,391 | 11.4 K to 16.4 K (+43.89 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 7.92 | 5,000 | 39,600 | 11,391 | 16.4 K to 11.4 K (-30.50 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.25 | 5,000 | 21,250 | 16,391 | 11.4 K to 16.4 K (+43.89 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 8.00 | 20,000 | 160,000 | 11,391 | 31.4 K to 11.4 K (-63.71 %) |
| Oct 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.25 | 20,000 | 85,000 | 31,391 | 11.4 K to 31.4 K (+175.58 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 1,626 | 12,049 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 500 | 3,719 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 8,000 | 59,504 | 500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 3,500 | 26,033 | 8,500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 12,000 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 13,500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,374 | 25,001 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,500 | 25,935 | 3,374 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 5,000 | 37,050 | 6,874 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 2,500 | 18,525 | 11,874 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 1,626 | 12,862 | 10,530 | 12.2 K to 10.5 K (-13.38 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 1,626 | 12,049 | 12,156 | 10.5 K to 12.2 K (+15.44 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 3,374 | 26,688 | 10,530 | 13.9 K to 10.5 K (-24.27 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,374 | 25,001 | 13,904 | 10.5 K to 13.9 K (+32.04 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 3,500 | 27,752 | 10,530 | 14 K to 10.5 K (-24.95 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,500 | 25,935 | 14,030 | 10.5 K to 14 K (+33.24 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 5,000 | 39,650 | 10,530 | 15.5 K to 10.5 K (-32.20 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 5,000 | 37,050 | 15,530 | 10.5 K to 15.5 K (+47.48 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 2,500 | 19,855 | 10,530 | 13 K to 10.5 K (-19.19 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 2,500 | 18,525 | 13,030 | 10.5 K to 13 K (+23.74 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 500 | 3,971 | 10,530 | 11 K to 10.5 K (-4.53 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 500 | 3,719 | 11,030 | 10.5 K to 11 K (+4.75 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.95 | 8,000 | 63,600 | 10,530 | 18.5 K to 10.5 K (-43.17 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 8,000 | 59,504 | 18,530 | 10.5 K to 18.5 K (+75.97 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 3,500 | 27,846 | 10,530 | 14 K to 10.5 K (-24.95 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 3,500 | 26,033 | 14,030 | 10.5 K to 14 K (+33.24 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 1,500 | 11,943 | 10,530 | 12 K to 10.5 K (-12.47 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 8.10 | 1,500 | 12,146 | 10,530 | 12 K to 10.5 K (-12.47 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.00 | 4,000 | 16,000 | 2,000 | |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.00 | 8,000 | 32,000 | 6,000 | |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Option Exercise | M | 4.00 | 4,000 | 16,000 | 14,000 | |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 8.71 | 4,000 | 34,836 | 11,391 | 15.4 K to 11.4 K (-25.99 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.00 | 4,000 | 16,000 | 15,391 | 11.4 K to 15.4 K (+35.12 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 8.71 | 8,000 | 69,672 | 11,391 | 19.4 K to 11.4 K (-41.26 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.00 | 8,000 | 32,000 | 19,391 | 11.4 K to 19.4 K (+70.23 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Sell | S | 8.71 | 4,000 | 34,836 | 11,391 | 15.4 K to 11.4 K (-25.99 %) |
| Jul 15 2004 | REGN | REGENERON PHARMACE ... | RUPP RANDALL | SVP, Manuf & Proce ... | Buy | M | 4.00 | 4,000 | 16,000 | 15,391 | 11.4 K to 15.4 K (+35.12 %) |
| Jul 12 2004 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Sell | S | 9.13 | 17 | 155 | 10,132 | 10.1 K to 10.1 K (-0.17 %) |
| Jul 12 2004 | REGN | REGENERON PHARMACE ... | KOLINSKI STUART | VP, Gen Counsel & S ... | Sell | S | 9.14 | 838 | 7,659 | 10,149 | 11 K to 10.1 K (-7.63 %) |
| Jun 28 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 245,682 | 0 | 245,682 | 0 to 245.7 K |
| Jun 28 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 245,682 | 0 | 851 | 246.5 K to 851 (-99.65 %) |
| Jun 21 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Sell | J | 0.00 | 189,345 | 0 | 10,655 | 200 K to 10.7 K (-94.67 %) |
| Jun 21 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Buy | J | 0.00 | 189,345 | 0 | 246,533 | 57.2 K to 246.5 K (+331.09 %) |
| Jun 21 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 5,172 | 0 | 57,188 | 62.4 K to 57.2 K (-8.29 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 15,900 | 0 | 572,585 | 588.5 K to 572.6 K (-2.70 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 200,000 | 0 | 62,360 | 262.4 K to 62.4 K (-76.23 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,363 | 0 | 262,360 | 266.7 K to 262.4 K (-1.64 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,521 | 0 | 266,723 | 271.2 K to 266.7 K (-1.67 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,282 | 0 | 271,040 | 275.3 K to 271 K (-1.56 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 3,636 | 0 | 275,322 | 279 K to 275.3 K (-1.30 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 15,900 | 0 | 572,585 | 588.5 K to 572.6 K (-2.70 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 200,000 | 0 | 62,360 | 262.4 K to 62.4 K (-76.23 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,363 | 0 | 262,360 | 266.7 K to 262.4 K (-1.64 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,521 | 0 | 266,723 | 271.2 K to 266.7 K (-1.67 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 4,282 | 0 | 271,040 | 275.3 K to 271 K (-1.56 %) |
| May 19 2004 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Director | Gift | G | 0.00 | 3,636 | 0 | 275,322 | 279 K to 275.3 K (-1.30 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 20,000 | 148,760 | 15,000 | |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 2,000 | 27,000 | 10,530 | 12.5 K to 10.5 K (-15.96 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 20,000 | 270,000 | 12,530 | 32.5 K to 12.5 K (-61.48 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 20,000 | 148,760 | 32,530 | 12.5 K to 32.5 K (+159.62 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 6.00 | 5,000 | 30,000 | 65,000 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 13.05 | 5,000 | 65,250 | 0 | 5 K to 0 (-100.00 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 6.00 | 5,000 | 30,000 | 5,000 | 0 to 5 K |
| Apr 23 2004 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP, PreclinDevel & ... | Gift | G | 19.65 | 250 | 4,913 | 15,482 | 15.7 K to 15.5 K (-1.59 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 6.00 | 8,200 | 49,200 | 43,000 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 6.00 | 1,000 | 6,000 | 51,200 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 6.00 | 500 | 3,000 | 52,200 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 6.00 | 200 | 1,200 | 52,700 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 6.00 | 100 | 600 | 52,900 | |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 12.63 | 8,200 | 103,566 | 5,258 | 13.5 K to 5.3 K (-60.93 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 6.00 | 8,200 | 49,200 | 13,458 | 5.3 K to 13.5 K (+155.95 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 12.39 | 1,000 | 12,390 | 5,258 | 6.3 K to 5.3 K (-15.98 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 6.00 | 1,000 | 6,000 | 6,258 | 5.3 K to 6.3 K (+19.02 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 12.64 | 500 | 6,320 | 5,258 | 5.8 K to 5.3 K (-8.68 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 6.00 | 500 | 3,000 | 5,758 | 5.3 K to 5.8 K (+9.51 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 12.54 | 200 | 2,508 | 5,258 | 5.5 K to 5.3 K (-3.66 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 6.00 | 200 | 1,200 | 5,458 | 5.3 K to 5.5 K (+3.80 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 12.59 | 100 | 1,259 | 5,258 | 5.4 K to 5.3 K (-1.87 %) |
| May 05 2004 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 6.00 | 100 | 600 | 5,358 | 5.3 K to 5.4 K (+1.90 %) |
| Mar 19 2004 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | G | 0.00 | 3,000 | 0 | 79,911 | |
| Mar 03 2004 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 14.00 | 5,000 | 70,000 | 0 | |
| Mar 03 2004 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Payment of Exercise | F | 14.76 | 4,742 | 69,992 | 72,772 | 77.5 K to 72.8 K (-6.12 %) |